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Abstract 
Signal transducers and activators of tran-
scription 3 (STAT3) has been identified as an
important signal transducer in the invasive
phenotype of the trophoblasts cells in in vitro
studies. However, the in situ distribution and
patterns of expression of this molecule in tro-
phoblast cells during the development of the
placenta are still under-elucidated. Mice uteri
of gestational ages between 7 and 14 days of
pregnancy (dop) were fixed in methacarn and
processed with immunoperoxidase techniques
for detection of STAT3 and its phosphorylation
at serine (p-ser727) residues, as well as the
suppressor of cytokine signaling 3 (SOCS3)
expression. STAT3 was observed at 7 through 9
dop in both the antimesometrial and mesome-
trial deciduas, while continued immunoreactiv-
ity between 10 and 13 dop was seen only in the
mesometrial decidua. In the placenta, STAT3
was detected in the cytotrophoblast cells of
labyrinth and giant trophoblast cells between
10 and 14 dop. Immunoreactivity for STAT3 was
also seen in trophoblast cells surrounding the
maternal blood vessels. On days 10 and 11 of
pregnancy, p-ser727 was detectable in the
mesometrial decidua and in giant trophoblasts,
while during 12-14 dop in the spongiotro-
phoblast region. In addition, SOCS3 was
immunodetected in maternal and placental tis-
sues, principally in the giant trophoblast cells
during the whole period of the study. The pres-
ent in situ study shows the distribution of
STAT3, its serine activation and SOCS3 in dif-
ferent maternal and fetal compartments during
murine placental development, thus further
supporting the idea that they play a role during
physiological placentation in mice. 
Introduction 
Trophoblast function during implantation
and placentation is essential for reproduction
in mammals. Some fertility impairments or
obstetric pathologies are due to a molecular
level dysfunction at the materno-fetal inter-
phase. If these alterations occur during the
initial steps of pregnancy, a number of
pathologies with severe consequences for
pregnancy and the future development of the
organism may follow.1-3
The basic phases of trophoblast differentia-
tion and placental development are common
among species that have haemochorial pla-
centation, such as rodents, non-human pri-
mates, and humans.4 In rodents, placentation
begins with trophoblast cell proliferation,
which then forms the ectoplacental cone. The
cone-derived cells then differentiate to form
the labyrinth, the spongiotrophoblast layer,
and the giant cell compartment. These struc-
tures constitute the foetal interface with the
maternal decidua.4-7 Recently, a correlation
between regulation of trophoblast functions
and intracellular Stat signalling has been
demonstrated. A member of this family,
Signal transducers and activators of tran-
scription 3 (STAT3), can be activated by a
variety of growth factors and cytokines,
which, via specific receptors, induce its phos-
phorylation and translocation into the nucle-
us. This process culminates with the tran-
scription of several genes8,9 leading to an
invasive trophoblast phenotype.10
The involvement of STAT3 in the regulation
of the invasive phenotype of trophoblast and
choriocarcinoma cells has been confirmed by
RNA interference in in vitro experiments.11
Furthermore, the regulation of this transduc-
tion pathway depends on leukaemia inhibito-
ry factor (LIF).12,13 On the other hand, LIF is
present in the endometrium during implanta-
tion and decidualisation, suggesting a molec-
ular interplay between uterus and embryo
that appears to be necessary for the establish-
ment of the maternal-fetal interface. Besides
the existent knowledge concerning the regu-
lation and activity of STAT3 in the trophoblast
cell in in vitro experiments, it is little known
whether these molecules and their activating
signals emerge in situ during the process of
trophoblastic invasion and initial placental
development. Since LIF- or STAT3-deficiency
leads to either infertility per implantation
failure or early pregnancy loss in the murine
model, much work has been dedicated to LIF
and STAT3 signalling of the early pre- and
postimplantation period of the mouse,14 espe-
cially in terms of decidualisation. However,
recent findings indicate that LIF and STAT3
signaling is also vital for proper placental
development, mainly through control of tro-
phoblast subset differentiation. The suppres-
sor of cytokine signaling 3 (SOCS3), a nega-
tive regulator of STAT3, when deficient, leads
to midgestational fetal demise due to placen-
tal insufficiencies secondary to maldifferenti-
ated trophoblast subsets. It was corroborated,
that this signal to differentiate was driven
through LIF, since LIF receptor blockage in
this model could rescue the offspring.15,16
For this reason, it was our objective to
obtain information on STAT3 and its regula-
tion pattern (serine activation of STAT3 and
SOCS3) during main stages of murine pla-
cental development through in situ experi-
ments at 7-14 days of pregnancy (dop). This
information is crucial to help validate the
hypotheses that regulation of the STAT3 sig-
nalling pathways in fact plays a role in regu-
lating the phenotype and function of tro-
phoblast cells.
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Materials and Methods
Animals
All experiments were conducted in accor-
dance with the ethical principles of animal
research adopted by the Brazilian College of
Animal Experimentation. The study design
was approved by the joint Ethics in Animal
Research Committee of the Institute of
Biomedical Sciences and the University of Sao
Paulo (authorisation no. 115/2000). Fourteen
female Swiss mice were obtained at 14 weeks
of age from colonies maintained at the Animal
Facilities of the Institute of Biomedical
Sciences. The mice were housed in a tempera-
ture controlled environment (21±1°C), main-
tained at a 12-h light/dark cycle, and given free
access to tap water and standard rat food Each
female was housed with a male for the purpose
of copulation. The vaginal plug was observed
daily, and the day on which the vaginal plug
was found was considered day 1 of pregnancy
(term, 20 days). The mice were weighed and
sacrificed on days 7 to 14 of pregnancy. Tissue collection
The uteri samples of each pregnant mice
were removed, fixed in methacarn solution
(absolute methanol, chloroform, glacial acetic
acid; 6:3:1) for 3 h at 4°C, and embedded in
Paraplast (Oxford, St. Louis, MO, USA) at
60°C. Sections of 5 µm in thickness were cut
and adhered to glass slides using 0.1% poly-L-
Lysine (Sigma) and then dried at room tem-
perature (25°C). Prior to the immunoreaction,
some samples were stained with haematoxylin
and eosin for morphological studies.Antibodies
Table 1 lists the antibodies used in the pres-
ent study. All antibodies were polyclonal anti-
bodies raised in rabbit. The antibody against
STAT3 recognizes the molecule independent
from the activation status and all splicing vari-
ants. The antibody against phospho STAT3
(Ser727) is specific for the respective phos-
phorylation site (all from Cell Signaling
Technology, Danvers, MA, USA). The SOCS3
antibody recognizes any status of the molecule
and was purchased from Santa Cruz
Biotechnology (USA). The secondary antibody
for detection was a biotin-conjugated goat
anti-rabbit IgG (Rockland, Gilbertsville, PA,
USA).Immunoperoxidase procedures 
Sections (5 µm) were cut, deparaffinized
and rehydrated. Antigen retrieval was per-
formed by incubating the sections in 10 mM
acetate sodium buffer (pH 6.0) at 95°C for 10
min. Each of the succeeding steps was fol-
lowed by a thorough rinse with PBS. All steps
were performed in a humid chamber, and care
was taken to avoid the desiccation of the sec-
tions. Non-specific staining was blocked by
incubation with 5% of normal goat serum
Original Paper
Table 1. Primary antibodies used in this study.
Primary Specificity Working 
Antibodies dilution
Polyclonal (cat n.9132) Anti-STAT3 1:50
Cell Signaling Technology, (Detects endogenous
Danvers, MA, USA levels of total STAT3 protein)
Polyclonal (cat n.9134) Anti-Phospho-STAT3 (Ser727) 1:100
Cell Signaling Technology, (Detects endogenous levels
Danvers, MA, USA of STAT3 only when
phosphorylated at Ser727)
Polyclonal (cat n. sc9023) Anti-SOCS3 1:100
Santa Cruz Biotechnology, (Detects amino acids
Dallas, TX, USA 87-189 of  SOCS3)
Table 2. Map of STAT3, phospho-serine STAT3 (p-ser-STAT3) and SOCS3 expression within murine uteri between gestational days 7-
14. This table offers an overview of when and where respective protein expression is detected within gravid murine uteri. 
Gestational day 7 8 9 10 11 12 13 14
Protein
Mesometrial decidua + + + + + + + + + + + +↓ + +↓ + +↓ +
Antimesometrial decidua + + + + + + +
Epitelium of uterine lumen + + +
(a)
Giant trophoblas + + +↑ + ++↑ + + +↑ + +↑ + +↑ + +↑
Labyrinthine trophoblast + + + + +↓ + + +
Spongio-trophoblast + + +↓ + + + + + +
Trophoblast surrounding +
maternal vessels
Uterine glands + + + + +
Myometrium + +
Endothelium of maternal + + + + + + + +
vessels
(a) indicates the detection in only antimesometrial region. Arrows up (↑) and down (↓) indicate the tendency of signal intensity in comparison to the earlier day.
ST
AT
3
p-
se
r-
ST
AT
3
ST
AT
3
p-
se
r-
ST
AT
3
SO
CS
3
ST
AT
3
p-
se
r-
ST
AT
3
SO
CS
3
ST
AT
3
p-
se
r-
ST
AT
3
SO
CS
3
ST
AT
3
p-
se
r-
ST
AT
3
SO
CS
3
ST
AT
3
p-
se
r-
ST
AT
3
SO
CS
3
ST
AT
3
p-
se
r-
ST
AT
3
SO
CS
3
ST
AT
3
p-
se
r-
ST
AT
3
SO
CS
3
ST
AT
3
p-
se
r-
ST
AT
3
SO
CS
3No
n-c
om
me
rci
al 
us
e o
nly
[page 120] [European Journal of Histochemistry 2013; 57:e19]
(Sigma)/PBS/Tween 20 for 1 h and 10 min in
Cas-Block solution (Zymed Laboratories,
South San Francisco, CA, USA). 
Sections were incubated with the primary
antibodies diluted in PBS containing 0.3%
(v/v) Tween 20, overnight at 4°C. After exten-
sive rinsing in PBS, all sections were incubat-
ed for 1 h at room temperature with biotin-con-
jugated goat anti-rabbit IgG, diluted 1:1000 in
PBS. After rinsing in PBS, sections were incu-
bated with Vectastain ABC kit (Vector) for 1 h
at room temperature. Peroxidase reaction was
visualised using NovaRED kit (Vector,
Burlingame, CA, USA) Following immunos-
taining, sections were lightly stained with
Mayer’s haematoxylin (Merck, Darmstadt,
Germany). For each immunohistochemical
reaction, controls were performed by incubat-
ing the sections with normal rabbit serum or
by omitting the primary antibody. Sections
were examined in a Zeiss Axioskop 2 micro-
scope, and the images were captured using a
digital camera (Canon) and KS 100 3.0 soft-
ware (Zeiss). 
ResultsImmunoperoxidase staining STAT3
On day 7 of pregnancy, STAT3 was detected
in the cytoplasm and nucleus of decidual and
predecidual cells, in both, antimesometrial
region (Figure 1a) and mesometrial region, as
well as in uterine glands (Figure 1b). Similar
distribution was found on day 8 of pregnancy.
On day 9, STAT3 was observed in the nucleus
of giant trophoblast cells and the cytoplasm of
epithelial cells of the forming new uterine
lumen (Figure 1c). By day 10 of pregnancy,
STAT3 was expressed in the mesometrial
decidua and cells surrounding the maternal
blood vessels (Figure 1d). In the antimesome-
trial region, STAT3 was only detectable in the
epithelium of the new uterine lumen. By day
10, labyrinth (Figure 1e) and giant tro-
phoblasts cells (Figure 1f) could be discrimi-
nated in the placenta and both were
immunoreactive for STAT3. On day 11 of preg-
nancy, the distribution of STAT3 in the
mesometrial decidua and placental regions
remains similar to the previous days.
Additionally, STAT3 was expressed in the spon-
giotrophoblast region. This pattern of
immunoreaction was maintained in placentas
collected on days 12 and 14 of pregnancy, how-
ever, from day 12 onwards, the immunoreac-
tion for STAT3 decreased in the mesometrial
decidua (Figure 1f).Phospho-STAT3 (Ser727) 
The phosphorylation of STAT3 at its ser-
ine727 residue was detectable from day 7 of
pregnancy in the cytoplasm of decidual and
predecidual cell of antimesometrial region as
well as in the uterine glands. On days 8 and 9
of pregnancy, phospho-STAT3 (Ser727) is
maintained in these regions (Figure 2a),
whereas on day 9, phosphorylation was also
detected in the epithelium of the new uterine
lumen (Figure 2b). 
On day 10 and 11 of pregnancy, phospho-
STAT3 (Ser727) was detectable in the
mesometrial decidua (Figure 2c) and giant tro-
phoblasts cells (Figure 2d).  On day 12 of preg-
nancy, phospho-STAT3 (ser727) was found in
the spongiotrophoblasts region of the placenta
(Figure 2e), which was the only the positive
region observed on days 13 and 14 of pregnan-
cy (Figure 2f). SOCS3
On day 7 of pregnancy, SOCS3 was
detectable in the cytoplasm of decidual and
predecidual cells, in both antimesometrial
region (Figure 3a) and mesometrial region, as
well as in the myometrium and endothelium of
maternal blood vessels (Figure 3b). In contrast
Original Paper
Figure 1. Immunoperoxidase staining for STAT3. a) Transversal cut of uterus on day 7,
immunoreaction is evident in the decidual and predecidual cell. b) In the same day
observe the immunolocalization of STAT3 in uterine glands. c) Transversal cut of uterus
on day 9, show the STAT3 in the nucleus of giant trophoblast cells (asterisk), in the decid-
ual cells and epithelium of the new light (arrow). d) In day 10, STAT3 is distributed in
the placental tissues and in the mesometrial decidua (MD) and e) in the labyrinth region,
STAT3 is observed in the trophoblast cells (arrows). f ) In day 12, minor presences of
STAT3 are observed in the mesometrial deciduas (MD), however in the placental tissues
the immunoreaction is maintained. g, h, i) Representative negative control of immuno-
histochemistry. AD, antimesometrial deciduas; S,  spongiotrophoblast region; mBV,
maternal blood vessels; *, giant trophoblast cells. Scale bar: 100 µm.
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to STAT3, SOCS3 was not expressed in the
uterine glands. On day 8 at 10 of pregnancy,
the expression of SOCS3 was maintained, sim-
ilar to the previous day. Additional immunore-
action for SOCS3 was observed in the labyrinth
and giant trophoblast cells (Figure 3c). From
day 9 to day 14 of pregnancy, SOCS3 was
detected in the mesometrial deciduas (Figure
3d), endothelium of maternal blood vessel
(Figure 3e) and progressive elevation of
immunoreactivity was detected in the giant
trophoblast cells during these days of pregnan-
cy (Figure 3f).
Discussion
Previous results in mice and rat showed that
STAT3 activation may be important for embryo
implantation and decidualisation, and may
also be regulated by maternal estrogen.14-17.
The first two days of our study timeline over-
laps with the timeline of the Teng group, and
our findings coincide. Embryo implantation
and development demands a complex
sequence of cellular and molecular modifica-
tions in the uterus. These include remodelling
of the uterine lumen, synthesis and degrada-
tion of extracellular matrix (ECM), recruit-
ment of immune-competent cells and an
increasing vascular permeability.18 Moreover,
preceding embryo implantation, a wave of cell
proliferation occurs in the endometrium and is
followed by re-differentiation of endometrial
fibroblasts into decidual cells;19 however, the
exact mechanisms of this process continue to
be poorly understood.
STAT3 have been implicated in several bio-
logical processes, such as growth, differentia-
tion, survival and apoptosis,20 all these
processes are observed during early pregnan-
cy. The achievements of the decidual pheno-
type depend on several growth factors and
cytokines, such as leukaemia inhibitory factor
(LIF).21 This molecule is associated with the
activation of STAT3 promoting the phosphory-
lation and nuclear translocation of STAT3 in
the mouse uterus; indicating that LIF is the
principal mediator of STAT3 activation in
vivo.12 Since, as Teng et al.14 demonstrate, also
pseudopregnant mice which decidualise their
tissue, also express and activate STAT3, it can
be assumed that the LIF signal at this time is
not originating from the embryo. Fitzgerald et
al.13 showed that LIF elicited strong tyrosine
phosphorylation and specific DNA-binding
activity of STAT3 in Jeg-3 choriocarcinoma cell
lines, inducing a significant acceleration of
cell proliferation and promoted the capability
of these cells to invade into an artificial extra-
cellular matrix. In addition we showed that
STAT3 are present in trophoblast derived cells,
particularly for invasive trophoblast cells, sug-
gesting a connection between STAT3 activity
and invasiveness of trophoblast cells. The
inducible suppressor of cytokine signalling
(Socs) proteins,  are expressed in response to
cytokine stimulation of Stat phosphorylation
acting in a negative-feedback mechanism to
hinder the activities of cytokine receptors.22 In
general, the transcription of genes encoding
SOCS3 is rapidly induced by exposure to
cytokines, and SOCS3 mRNA induction
appears to be dependent on the activity of
STAT3.23 In our study, SOCS3 was detected in
the decidua labyrinth region and the giant tro-
phoblast cells, in a fashion the similar to
STAT3 distribution. Previous study showed
that in the absence of SOCS3, embryos appar-
ently develop normally until the 10th day of
Original Paper
Figure 2. Immunoperoxidase staining for Phospho-STAT3 (Ser727). a) Transversal cut of
uterus on day 8, immunoreaction is strong in the cytoplasm of decidual and predecidual
cell. b) This reaction continues on day 9, however immunoreaction for Serine STAT3 was
not observed in the giant trophoblast cells (asterisk); arrow shows the immunoreaction in
the epithelium of the new light. c) Mesometrial deciduas on day 11, show immunoreac-
tion in this cells and surrounding the maternal blood vessels (mBV). d) In this day
observe the immunoreaction in the cytoplasm of the giant trophoblast cells (asterisk). e)
Spongiotrophoblast region on day 12, show immunoreaction. (f ): This reaction increase
on days 13 and 14. g, h, i) Representative negative control of immunohistochemistry. AD,
antimesometrial deciduas; S, spongiotrophoblast region. Scale bar: 100 µm.
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pregnancy, but died between days 11 and 13,
where the formation of spongiotrophoblast and
the morphogenesis of the labyrinth are affect-
ed.15
Takahashi et al.16 did one in situ hybridiza-
tion staining at placentas from E9.5, show
SOCS3 was expressed in all trophoblast line-
age including the trophoblast stem cell popula-
tion in ectoplacental cone, chorion and pri-
mary giant cells. This is in correlation to our
results, however we observed that 12 day
onward SOCS3 was detected principally associ-
ated with giant trophoblast cells. At our part,
we see that SOCS3 is generated in the tro-
phoblast subsets starting from day 8 of preg-
nancy. It is appealing to hypothesize, that
SOCS3 expression at this time is tolerable to a
certain degree, but as the demands of fetal
development increases, the placental insuffi-
ciency deriving from SOCS3 deficiency cannot
be compensated for longer than E13. SOCS3
modulate the Stat signal transduction,24 the
absence of SOCS3 can be related with the
maintenance of STAT3 resulting in an altered
cell function.
Another mechanism geared toward main-
taining balance in the Stat and MAPK system
is serine phosphorylation of STAT3. The defin-
itive function of serine phosphorylation of
STAT3 is under controversy since serine phos-
phorylation has been seen to both boost as well
as inhibit STAT3 activity. The current para-
digm is that serine phospho STAT3 interferes
with tyrosine phosphorylation of Stat. Serine
phosphorylation is accomplished or mediated
by members of several other signalling path-
way families, such as (but not exclusively)
ERK, MAPK, PKCdelta, mTOR, PI3K/AKT, but
there is a paucity in defining which mediators
enhance and which down-regulated the tran-
scriptional activity of this protein, and which
effect it has on cell function.25 Interestingly,
the serine phosphorylation of STAT3 was
detected especially in the spongiotrophoblast
cells of placenta starting from day 12.
Coinciding to this time, it seems that fetal
demise begins. It is within the range of possi-
bility that this further signal leads to a further
activation of the ERK/MAPK pathway, possibly
leading to final demise of the embryo.
Finally, the balance between the expression
and activation of STAT3 and its inhibitor
SOCS3 could be essential for decidualisation
and normal placental development in mice.   
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